Fig. 4From: Circulating lnc-LOC as a novel noninvasive biomarker in the treatment surveillance of acute promyelocytic leukaemiaUtilization of PB lnc-LOC in monitoring the treatment response of APL patients. a PB lnc-LOC expression in 40 APL patients at new diagnosis, postinduction and CR. b PB lnc-LOC expression in 5 representative relapsed APL patients at different periods (at diagnosis, CR and relapse). * Statistically significantBack to article page